Daily Stock Ratings & Price Targets

Daily stock ratings from over 8,000 Wall Street analysts

Daily Buy Ratings

Analyst & Firm	Company	Rating & Price Target	Upside / Downside
Kyle VoigtKBW	PWP Perella Weinberg Partners	BUY$22	24.43% Upside
Joseph MooreMorgan Stanley	ALAB Astera Labs, Inc.	BUY$99	39.04% Upside
Aaron HechtCitizens JMP	AHR American Healthcare REIT, Inc.	BUY$40	14.51% Upside
Bose GeorgeKBW	ESNT Essent Group	BUY$65	11.05% Upside

Daily Sell Ratings

Analyst & Firm	Company	Rating & Price Target	Upside / Downside
Jade RahmaniKBW	CMTG Claros Mortgage Trust	SELL$2.25	-7.41% Downside
Adrienne YihBarclays	AEO American Eagle	SELL$9	-19.21% Downside
Jason GoldbergBarclays	ZION Zions Bancorporation National Association	SELL$61	31.15% Upside
Lauren LiebermanBarclays	COTY Coty	SELL$4.5	-4.05% Downside

Full List of Stock Ratings

(May 12, 2025)

Analyst Performance

Any

Analyst Rating

Any

Upside / Downside

Any

Action

Any

Market Cap

Any

Analyst & Firm	Company	Rating & Price Target	Upside / Downside	Average Return	Action	Date	Article
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $2→$2.5	―	4.20%	Reiterated	2025-05-12
Brendan SmithTD Cowen	TKNO Alpha Teknova	BUY $10	―	-6.90%	Reiterated	2025-05-12	Alpha Teknova's Growth Potential and Strategic Strengths Highlighted in Analyst Buy Rating
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $45→$40	―	3.40%	Reiterated	2025-05-12
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $97→$88	―	6.60%	Reiterated	2025-05-12
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $5.75	―	13.30%	Reiterated	2025-05-12
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $1.8	―	13.30%	Reiterated	2025-05-12
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $111→$100	―	6.60%	Reiterated	2025-05-12
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $13→$9	―	12.60%	Downgraded	2025-05-12
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $8.25→$7.5	―	13.30%	Reiterated	2025-05-12
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $293	―	6.60%	Reiterated	2025-05-12
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $4→$2	―	3.30%	Reiterated	2025-05-12
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $192	―	21.70%	Reiterated	2025-05-12
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $1.2→$1.4	―	2.50%	Reiterated	2025-05-12
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $23	―	6.60%	Reiterated	2025-05-12
Betty JiangBarclays	STR Sitio Royalties	HOLD $21	―	-3.60%	Reiterated	2025-05-12	Analysts Offer Insights on Energy Companies: Phillips 66 (NYSE: PSX) and Sitio Royalties (NYSE: STR)
Andrew Mok CFABarclays	ASTH Astrana Health	HOLD $36	―	-8.10%	Reiterated	2025-05-12	Analysts Offer Insights on Healthcare Companies: Astrana Health (NASDAQ: ASTH) and Amphastar Pharmaceuticals (NASDAQ: AMPH)
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	SELL $111	―	6.60%	Reiterated	2025-05-12
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	SELL $4.5	―	2.50%	Reiterated	2025-05-12
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $15	―	7.80%	Reiterated	2025-05-12
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $26	―	14.40%	Reiterated	2025-05-12
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $22→$23	―	2.50%	Reiterated	2025-05-12
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $60→$57	―	2.50%	Reiterated	2025-05-12
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $49	―	4.20%	Reiterated	2025-05-12
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $95	―	12.50%	Reiterated	2025-05-12
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $58	―	6.20%	Reiterated	2025-05-12
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $2,400	―	12.50%	Reiterated	2025-05-12
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $145	―	8.70%	Reiterated	2025-05-12
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	SELL $61	―	12.50%	Reiterated	2025-05-12
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $86	―	0.80%	Reiterated	2025-05-12
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $266	―	6.30%	Reiterated	2025-05-12
Andrew Mok CFABarclays	RDNT Radnet	BUY $60	―	-8.10%	Reiterated	2025-05-12	Analysts Offer Insights on Healthcare Companies: Radnet (NASDAQ: RDNT), CSL (Other OTC: CMXHF) and BioMarin Pharmaceutical (NASDAQ: BMRN)
Peter LawsonBarclays	SWTX Springworks Therapeutics	HOLD $47	―	-12.60%	Reiterated	2025-05-12	Barclays Sticks to Its Hold Rating for Springworks Therapeutics (SWTX)
Dan LevyBarclays	CAR Avis Budget	HOLD $105	―	-4.20%	Reiterated	2025-05-12	Analysts Offer Insights on Industrial Goods Companies: Transdigm Group (NYSE: TDG), Kennametal (NYSE: KMT) and Avis Budget (NASDAQ: CAR)
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $210	―	9.30%	Reiterated	2025-05-12
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $15	―	11.30%	Reiterated	2025-05-12
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $61	―	13.40%	Reiterated	2025-05-12
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $48→$60	―	7.80%	Reiterated	2025-05-12
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $405	―	14.40%	Reiterated	2025-05-12
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $213	―	14.40%	Reiterated	2025-05-12
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	SELL $10→$9	―	5.10%	Reiterated	2025-05-12
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $38→$31	―	5.10%	Reiterated	2025-05-12
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $329→$254	―	5.10%	Reiterated	2025-05-12
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $29→$26	―	3.30%	Reiterated	2025-05-12
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $254→$223	―	5.10%	Reiterated	2025-05-12
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $102→$108	―	4.20%	Reiterated	2025-05-12
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $24→$14	―	5.10%	Reiterated	2025-05-12
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $29→$32	―	16.10%	Reiterated	2025-05-12
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $22→$24	―	8.20%	Reiterated	2025-05-12
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $69→$61	―	3.30%	Reiterated	2025-05-12
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $309→$276	―	5.10%	Reiterated	2025-05-12

Rows:

Ready for the Full Picture?Your current plan limits your access to top-tier analyst ratings. Subscribe to Premium now and unlock the full range of ratings from the highest-ranked analysts on Wall Street. Don't let partial views limit your market research potential - upgrade today!

Upgrade Now Plans & Pricing